New drug combo aims to outsmart resistant ovarian cancer
NCT ID NCT04633239
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 3 times
Summary
This early-phase trial is testing whether combining two targeted drugs—abemaciclib and olaparib—can help women with ovarian cancer that has stopped responding to platinum-based chemotherapy. The study will enroll 42 participants to find the safest dose and check for side effects. Researchers hope the drug pair can slow or shrink tumors by blocking cancer cell growth and DNA repair.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- abemaciclib and olaparib
- What this could lead to
- If it works, this could lead to a new treatment option for women with ovarian cancer that has stopped responding to standard platinum-based chemotherapy.
- What could go wrong
- This is an early phase 1 trial with only 42 participants, so it is too small to prove effectiveness. The combination may cause significant side effects or fail to control the cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OVARIAN HIGH GRADE SEROUS ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Los Angeles General Medical Center
RECRUITINGLos Angeles, California, 90033, United States
Contact Email: •••••@•••••
-
Mayo Clinic Hospital in Arizona
ACTIVE_NOT_RECRUITINGPhoenix, Arizona, 85054, United States
-
Mayo Clinic in Florida
ACTIVE_NOT_RECRUITINGJacksonville, Florida, 32224-9980, United States
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
-
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
TERMINATEDNew York, New York, 10032, United States
-
Northwestern University
ACTIVE_NOT_RECRUITINGChicago, Illinois, 60611, United States
-
Ohio State University Comprehensive Cancer Center
RECRUITINGColumbus, Ohio, 43210, United States
-
Thomas Jefferson University Hospital
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
Contact Email: •••••@•••••
-
UC Irvine Health/Chao Family Comprehensive Cancer Center
RECRUITINGOrange, California, 92868, United States
Contact Email: •••••@•••••
-
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
RECRUITINGIrvine, California, 92612, United States
Contact Email: •••••@•••••
-
UM Sylvester Comprehensive Cancer Center at Coral Gables
ACTIVE_NOT_RECRUITINGCoral Gables, Florida, 33146, United States
-
UM Sylvester Comprehensive Cancer Center at Deerfield Beach
ACTIVE_NOT_RECRUITINGDeerfield Beach, Florida, 33442, United States
-
UM Sylvester Comprehensive Cancer Center at Plantation
ACTIVE_NOT_RECRUITINGPlantation, Florida, 33324, United States
-
USC / Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90033, United States
-
University of Kansas Cancer Center
SUSPENDEDKansas City, Kansas, 66160, United States
-
University of Kansas Cancer Center - Lee's Summit
SUSPENDEDLee's Summit, Missouri, 64064, United States
-
University of Kansas Cancer Center - North
SUSPENDEDKansas City, Missouri, 64154, United States
-
University of Kansas Cancer Center at North Kansas City Hospital
SUSPENDEDNorth Kansas City, Missouri, 64116, United States
-
University of Kansas Cancer Center-Overland Park
SUSPENDEDOverland Park, Kansas, 66210, United States
-
University of Kansas Clinical Research Center
RECRUITINGFairway, Kansas, 66205, United States
-
University of Kansas Hospital-Indian Creek Campus
SUSPENDEDOverland Park, Kansas, 66211, United States
-
University of Kansas Hospital-Westwood Cancer Center
SUSPENDEDWestwood, Kansas, 66205, United States
-
University of Miami Miller School of Medicine-Sylvester Cancer Center
ACTIVE_NOT_RECRUITINGMiami, Florida, 33136, United States
-
University of Oklahoma Health Sciences Center
RECRUITINGOklahoma City, Oklahoma, 73104, United States
-
University of Virginia Cancer Center
RECRUITINGCharlottesville, Virginia, 22908, United States
Contact Email: •••••@•••••
-
Vanderbilt University/Ingram Cancer Center
RECRUITINGNashville, Tennessee, 37232, United States
-
Wake Forest University Health Sciences
RECRUITINGWinston-Salem, North Carolina, 27157, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Vaccine-Immunotherapy combo takes aim at Hard-to-Treat ovarian cancer
- New vaccine combo shows promise in ovarian cancer fight
- New drug combo targets returned ovarian and uterine cancers
- New cocktail aims to boost immune attack on ovarian cancer
- New drug combo targets tough ovarian cancer in early trial
- New drug cocktail shows promise for Hard-to-Treat ovarian cancer